1例甲氨蝶呤治疗异位妊娠致严重不良反应患者的药学监护

doi:10.19803/j.1672-8629.20230616

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (4): 454-456.
DOI: 10.19803/j.1672-8629.20230616

1例甲氨蝶呤治疗异位妊娠致严重不良反应患者的药学监护

黎海燕, 杨忠旭^*, 刘跃昆, 王丽虹

安宁市第一人民医院药学部,云南安宁 650300

收稿日期:2023-09-28 出版日期:2024-04-15 发布日期:2024-04-18
通讯作者: ^*杨忠旭,男,本科,临床药学。E-mail:1920257670@qq.com
作者简介:黎海燕,女,本科,临床药学。

Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy

LI haiyan, YANG Zhongxu^*, LIU Yuekun, WANG Lihong

Department of Pharmacy, Anning First People's Hospital, Anning Yunnan 650300, China

Received:2023-09-28 Online:2024-04-15 Published:2024-04-18

摘要/Abstract

摘要： 目的报道基于中国医院药物警戒系统（CHPS）主动监测甲氨蝶呤治疗异位妊娠患者,探讨临床药师为患者提供药学监护的作用。方法分析临床药师通过CHPS主动监测某院异位妊娠患者在使用甲氨蝶呤治疗过程中出现的不良反应并积极参与用药方案调整过程。结果及结论 临床药师利用CHPS主动监测药品不良反应,及时协助临床参与不良反应救治,保证患者用药安全,探索临床药师服务新模式,提高医疗机构药学服务综合水平。

关键词: 异位妊娠, 甲氨蝶呤, 药品不良反应, 临床药师, 中国医院药物警戒系统, 药学监护

Abstract: Objective To monitor the use of methotrexate for the treatment of one ectopic pregnancy patient based on the China Hospital Pharmacovigilance System (CHPS) so as to explore the role of clinical pharmacists in providing pharmacological care. Methods The process in which clinical pharmacists monitored adverse reactions during methotrexate therapy in a patient with ectopic pregnancy through the CHPS and participated in revising the medication regimen was analyzed. Results and Conclusion Clinical pharmacists can monitor adverse drug reactions via the CHPS, assist clinicians in treating adverse reactions, ensure the safety of medication, and improve the quality of pharmacy services.

Key words: ectopic-pregnancy, methotrexate, adverse drug reactions, clinical pharmacist, Chinese Hospital Pharmacovigilance System, pharmaceutical care

中图分类号:

R984
R994.11

黎海燕, 杨忠旭, 刘跃昆, 王丽虹. 1例甲氨蝶呤治疗异位妊娠致严重不良反应患者的药学监护[J]. 中国药物警戒, 2024, 21(4): 454-456.

LI haiyan, YANG Zhongxu, LIU Yuekun, WANG Lihong. Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 454-456.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.zgywjj.com/CN/10.19803/j.1672-8629.20230616

https://www.zgywjj.com/CN/Y2024/V21/I4/454

参考文献

[1] SONG Z, HU Y, LIU S, et al.Medication therapy of high-dose methotrexate: an evidence-based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society[J]. Br J Clin Pharmacol, 2022, 88(5): 2456-2472.
[2] ZHANG CY, REN XL, FENG WY, et al.The effect of MTHFR and ABCB1 genetic polymorphism on serious toxicity and elimination delay of high dose methotrexate[J]. Chinese Journal of New Drugs(中国新药杂志), 2019, 28(1): 117-120.
[3] BAI XH, NIU HJ, NI MY, et al.Association of MTHFR gene polymorphism with efficacy and adverse drug reactions of high-dose methotrexate in the treatment of childhood acute lymphoblastic leukemia[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2021, 37(22): 3056-3059.
[4] LIU S, SONG ZW, YI ZM, et al.Hematotoxicity correlation of MTHFR gene polymorphism with high-dose of methotrexate in hematological neoplasm patients:a Meta-analysis[J]. China Pharmacy(中国药房), 2020, 31(7): 850-858.
[5] SONG ZW, HUANG ZC, ZHAO RS.Pharmacogenetics of methotrexate toxicity in patients with osteosarcoma or hematological malignancy: an umbrella review of systematic reviews[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2019, 35(9): 896-899.
[6] DENG GP, GAO J, ZHANG YX, et al.Tubal pregnancy diagnosis and treatment guide of integrated Chinese and western medicine[J]. Chinese Journal of Practical Gynecology and Obstetrics(中国实用妇科与产科杂志), 2021, 37(2): 172-180.
[7] PO L, THOMAS J, MILLS K, et al. Guideline No.414: management of pregnancy of unknown location and tubal and nontubal ectopic pregnancies[J]. J Obstet Gynaecol Can, 2021, 43(5): 614-630. e1.
[8] ALUR-GUPTA S, COONEY LG, SENAPATI S, et al. Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis[J]. American Journal of Obstetrics and Gynecology, 2019, 221(2): 95-108. e2.
[9] BARNHART KT, GOSMAN G, ASHBY R, et al.The medical management of ectopic pregnancy: a meta-analysis comparing ‘single dose'and‘multidose'regimens[J]. Obstetrics and Gynecology, 2003, 101(4): 778-784.
[10] YOU LN, XU H, XIA HY, et al.Retrospective analysis on methotrexate in the treatment of ectopic pregnancy[J]. Medical and Pharmacy of Yunnan(云南医药), 2022, 43(1): 24-27.
[11] XIE H, KONG BH, DUAN T.Obstetrics and Gynecology(妇产科学)[M]. 9th Edition. Beijing: People's Health Press, 2018: 74-79.
[12] GUO C, HUANG G, LIN F, et al.Expert consensus on high-dose methotrexate calcium folinate rescue therapy for malignant tumors[J]. Chinese Clinical Oncology(中国肿瘤临床), 2019, 46(15): 761-767.
[13] QIN SK, MA J.Chinese Society of Clinical Oncology (CSCO) guidelines for standardized management of tumor chemoradiotherapy-related neutropenia ( version 2021)[J]. Chinese Clinical Oncology(临床肿瘤学杂志), 2021, 26(7): 638-648.
[14] SUN ZM, HUANG XJ, WANG Y, et al.Guidelines for clinical application of antimicrobial drugs in Chinese patients with neutrophil deficiency with fever (2020 version)[J]. Chinese Journal of Hematology(中华血液学杂志), 2020, 41(12): 969-978.

[1]	杨波, 王梦娇, 胡丽丽, 王来成, 李倩, 孔飞飞, 吕冬梅, 沈佳妮. 385例PD-1抗肿瘤治疗的安全性研究及风险因素分析[J]. 中国药物警戒, 2024, 21(4): 447-450.
[2]	李少强, 孔旭东, 李朋梅. 注射用奥美拉唑钠致低钠血症1例分析[J]. 中国药物警戒, 2024, 21(4): 461-463.
[3]	伍诗琪, 闫素英, 张青霞. 艾多沙班药代动力学相互作用研究进展[J]. 中国药物警戒, 2024, 21(4): 473-480.
[4]	黄焕均, 麦嘉恒, 张云惠, 郭晨晨, 梁蔚婷. 613例抗肿瘤药物的不良反应分析[J]. 中国药物警戒, 2024, 21(3): 324-328.
[5]	刘琦, 张玉凤, 罗皓, 李歆. 106例安罗替尼临床应用的合理性与安全性分析[J]. 中国药物警戒, 2024, 21(3): 329-334.
[6]	吉秋霞, 金剑, 章斌. 特瑞普利单抗免疫相关不良事件药学监护[J]. 中国药物警戒, 2024, 21(3): 346-348.
[7]	陈杰, 张斌, 赵俊, 张传洲. 托珠单抗注射液致过敏性休克1例分析[J]. 中国药物警戒, 2024, 21(3): 349-351.
[8]	杨雪婷, 何波, 闫鸿丽, 李冬梅. 克拉霉素致急性短暂性抑郁症不良反应1例分析[J]. 中国药物警戒, 2024, 21(3): 352-354.
[9]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[10]	范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184.
[11]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[12]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[13]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[14]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[15]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.

1例甲氨蝶呤治疗异位妊娠致严重不良反应患者的药学监护

Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics